The hallmark of Parkinson’s disease is a misfolded protein in the body, called alpha-synuclein, that is implicated in the loss of dopamine neurons in the brain. When those dopamine neurons are lost, ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

Sep. 24, 2024 — Parkinson's disease ... and neurological disorders attributed to dysfunctions in specific dopamine ... Alzheimer's Drug May Slow Down Cognitive Decline in Dementia With Lewy ...

The findings shed light on the molecular mechanism behind the drug levodopa (L-Dopa), widely used to treat Parkinson's disease. A hallmark of the condition is progressively diminishing dopamine ...

New research links childhood adversity with later attention deficits, sleep disruptions, and specific dopamine imbalances in ...

while reward-oriented behaviors depend on rapid dopamine action. This distinction helps clarify how L-Dopa alleviates motor symptoms in Parkinson's disease but may not improve cognitive function.

Parkinson’s patients lack sufficient amounts of a neurotransmitter called dopamine. Standard treatment includes the drug levodopa, a compound that a brain enzyme converts into dopamine.

While Parkinson’s disease (PD) has a large and highly generalised ... All marketed PD products are symptomatic therapies, ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...